Username Password
S&P 500: 2,126.06
Change: -0.22%

MEDIVATION INC. (MDVN)

Overview
Price 128.87
Price Change Today -$2.45 (-1.87%)
P&P rating Rating: 2
Open Price $130.93
Previous Close $131.32
Daily Range $127.85 - $131.81
52-Week Range $68.31 - $141.58
Volume 1
chart
Top Buy Analysis
BUY: MDVN Rating: 2
Company: MEDIVATION INC.
Points: 244.05
Start Price: $31.37
Start Date: 09/03/2008 8:31 PM
beachdude
beachdude
P&P Score: 94.54
Recs:
Impressive management with great business strategy. good pipeline of new products

Comments: 0 | Comment

Top Sell Analysis
SELL: MDVN Rating: 2
Company: MEDIVATION INC.
Points: -193.87
Start Price: $33.42
Start Date: 12/01/2009 11:18 PM
BearNekkid
BearNekkid
P&P Score: 93.97
Recs:

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

12 Buy
1 Sell
 
Try it Free!
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.99 02/28/14 Market Sells off in the afternoon = High flyers taking a breather 6 02/28/14
zantriocom
0.00 03/16/10 Zantrio.com Free Daily Stock Picks 3-16-2010 0
Neurodoc
99.24 02/03/10 M&M boys up on healthy volume today 4 02/11/10
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/15/13 Eylea Drives Regeneron - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Priority Review for Bayer's Drug - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/14/13 Alexion 4Q Tops on Both Lines - Analyst Blog 0
Zacks_Analysts
0.00 02/12/13 Priority FDA Review for Celgene Drug - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   ...  14  >>
Commentary
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +479.32
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +481.06
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +480.81
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +479.32
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +481.06
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $19.70
Points: +480.81
Created: 09/18/2011
Good company getting better, with a promising new drug/approach for treating prostate cancer.

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +180.54
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +182.47
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +182.20
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
BUY: MEDIVATION INC. (MDVN) Rating: 2
Start Price: $34.34
Points: +180.54
Created: 01/23/2010
3 chances to make a significant earnings move and/or be bought

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +72.98% +149.12 view
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +71.26% +150.83 view
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +71.50% +150.59 view
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +72.98% +149.12 view
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +71.26% +150.83 view
Yade 43.39 BUY One to Three Years 11/09/2011 $40.01 $128.87
(-1.87%)
+222.09% +71.50% +150.59 view
COBeeMan 22.85 BUY Week to a Month 09/18/2011 $19.70 $128.87
(-1.87%)
+554.16% +74.84% +479.32 view
COBeeMan 22.85 BUY Week to a Month 09/18/2011 $19.70 $128.87
(-1.87%)
+554.16% +73.11% +481.06 view
COBeeMan 22.85 BUY Week to a Month 09/18/2011 $19.70 $128.87
(-1.87%)
+554.16% +73.35% +480.81 view
COBeeMan 22.85 BUY Week to a Month 09/18/2011 $19.70 $128.87
(-1.87%)
+554.16% +74.84% +479.32 view
Pages: [ 1 ]  2  >>
Sponsored Links